Zirabev

Indicated For

Metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer

About This Medication

# Pfizer Oncology Together Patient Guide: How to Get **Zirabev (bevacizumab-bvzr)** at Low or No Cost This guide explains how to access **Zirabev (bevacizumab-bvzr)**, a biosimilar to Avastin used to treat certain cancers like colorectal, lung, and kidney cancers, through the **Pfizer Oncology Together** program. It provides free or low-cost medication to eligible patients, helping reduce financial barriers to treatment. ## About Zirabev and Why Assistance Matters **Zirabev (bevacizumab-bvzr)** is an injectable medication that works by blocking a protein called VEGF, which helps tumors grow blood vessels. It's FDA-approved as a biosimilar to **Avastin (bevacizumab)**, the reference product, and is used in combination with other therapies for cancers including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, and epithelial ovarian/fallopian tube/primary peritoneal cancer. Oncology treatments like Zirabev can be very expensive, often costing tens of thousands per treatment cycle. The **Pfizer Oncology Together** program bridges this gap by offering free medicine through the Pfizer Patient Assistance Foundation for qualifying patients, plus co-pay support for others. ## Who Qualifies for Pfizer Oncology Together? Eligibility focuses on financial need, residency, and prescription validity. Key criteria include: - U.S. resident (including Puerto Rico) and 18 years or older. - Valid prescription for **Zirabev** from a U.S.-licensed healthcare provider (HCP) with an FDA-approved diagnosis. - **Household income at or below 300% of the Federal Poverty Level (FPL)**. This is lower than some programs' 400-500% thresholds, making it targeted for lower-income patients. - Available to uninsured, underinsured, commercially insured, and **Medicare Part D patients** (program verifies benefits and assists with Medicaid if eligible). **Note:** Exact income limits aren't always published upfront; call (877) 744-5675 for personalized details, as criteria can change. ## Income Eligibility Breakdown Income eligibility is based on **annual household income ≤ 300% FPL**. Use the table below for 2026 estimates (FPL updates annually; confirm current levels via program or HHS.gov). For a family of 4, 300% FPL is about $97,200; adjust for household size. | Household Size | 100% FPL (approx.) | 300% FPL Threshold (approx.) | |----------------|---------------------|------------------------------| | 1 (Individual) | $15,060 | $45,180 | | 2 (Couple) | $20,440 | $61,320 | | 3 | $25,820 | $77,460 | | 4 | $31,200 | $93,600 | | +1 Member | +$5,380 | +$16,140 | *Examples:* A single person earning ≤$45,180 may qualify. Provide proof like tax returns or pay stubs. Program helps check Medicaid eligibility first. ## Insurance Requirements The program is flexible: - **Uninsured or underinsured:** Primary option for free medicine. - **Commercially insured:** Co-pay savings available (as low as $0/month, limits apply; not for government insurance like VA/military). - **Medicare Part D:** Eligible; include Part D plan address and cards. Program verifies benefits and covers co-pays if qualified. - **Medicaid assistance:** Program screens and helps apply if eligible. Include front/back of all insurance cards. No coverage required for patient assistance, but benefit verification may be needed for co-pay help. ## Step-by-Step Application Process Applications are **multiple methods**—choose what's easiest. Both patient/caregiver and HCP must complete parts. 1. **Discuss with your doctor:** Confirm **Zirabev** prescription. HCP provides DEA/State NPI numbers. 2. **Gather documents:** Front/back insurance cards, financial proof (tax returns, W-2s, pay stubs), HCP details. 3. **Complete enrollment form** (8 pages): Patient/caregiver fills pages 1-5 (personal/financial info, insurance); HCP fills 6-8 (prescription, diagnosis confirmation in Section 13 if needed). 4. **Submit:** - **Phone support:** Call (877) 744-5675 (Mon-Fri 8am-8pm ET) for guidance. - **Online:** patientsupportnow.org (code: 8777366506) or pfizeroncologypatientenroll.com; HCPs use pfizeroncologytogether-portal.com. - **Fax:** 1-877-736-6506. - **Mail:** Pfizer Oncology Together, PO Box 220366, Charlotte, NC 28222-0366. 5. **Program reviews:** Includes benefit verification if insured. **Tip:** Use Pfizer PAP Connect at PfizerRxPathways.com for some meds; start there. ## Timeline and Delivery - **Processing:** Typically **24-72 hours** after complete submission. - **Approval notice:** Sent to you and HCP with details (e.g., co-pay card for injectables via PfizerCopay.com). - **Delivery:** **Varies**—direct to pharmacy, HCP office, or patient. For injectables, HCP submits claims within 180 days of treatment (include EOB). Free meds shipped as approved. ## Alternatives if Denied or Other Options - **Reapply:** Fix issues (e.g., income proof) and resubmit. - **Co-pay program:** If income too high, commercially insured patients may get savings (enroll at PfizerCopay.com). - **Biosimilar/reference:** **Avastin (bevacizumab)** is the reference product; check its assistance via separate programs. - **Other resources:** Program connects to Medicaid, state programs, or PfizerRxPathways.com finder. Non-Pfizer options like NeedyMeds.org or PAN Foundation. - **Bridge programs:** Ask about short-term help during appeals. ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026. Eligibility, terms, and availability can change; always verify with Pfizer Oncology Together at (877) 744-5675 or official sites. Not a guarantee of approval. Consult your doctor for medical advice. Pfizer Oncology Together is not insurance. Free medicine via Pfizer Patient Assistance Foundation, a separate entity. Limits apply (e.g., U.S. residents only).

Program information last verified: March 25, 2026